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The details  of the reaction mechanism of C3 have been extensively investi- 
gated  in  studies  employing  pure  complement  components  and  sensitized 
erythrocytes (1,  2).  The  dynamics of  these  reactions have  been  followed by 
radioisotope  labels  and  the  end  products  detected  and  identified  by  their 
sedimentation and electrophoretic characteristics. More recent studies (3) have 
focused on the reaction of C3 with certain enzymes such as trypsin, thrombin, 
plasmin, or the C3 inactivator complex formed from cobra venom and a serum 
beta globulin. Again these investigations have utilized purified substances and 
the  resulting  products have been  analyzed by many of the  same techniques 
used in earlier studies. 
The present investigation of the  reaction sequence of C3  differs  from those 
described  above in  that  (a)  an  immune precipitate  has  been  substituted  for 
sensitized  erythrocytes, (b)  the reaction has been  carried out in fresh human 
serum rather than with purified complement components, and (c) monospecific 
antisera to the antigenic determinants of C3  (4)  have been used to study the 
breakdown products formed. The use of sermn approximates in vivo conditions 
more closely than is possible with purified components, a feature which becomes 
important in assessing complement reactions in disease.  The use of monospecific 
antisera has added an additional parameter  to the characterization of the C3 
conversion products  and has allowed positive identification  of these products 
after electrophoresis in acrylamide or agar, despite the presence of contaminat- 
ing serum proteins. The present paper deals primarily with  the identification 
of the C3 conversion products as they occur in the fluid phase during the reac- 
tion of fresh human serum with an immune precipitate. In addition, the kinetics 
of  this  fluid-phase  reaction  have  been  studied.  Subsequent  communications 
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will deal with the qualitative and quantitative aspects of the bound phase, i.e., 
the deposition of C3  on the immune complex. 
Materials and Methods 
Specific Antisera to A, B, and D Antigens of C3.--To produce antibody to B and D determi- 
nants of C3,  goats were immunized with purified C3  (5)  incorporated in complete Freund's 
adjuvant. Approximately 1 mg was given at each of 10 subcutaneous sites at each of three 
immunizations 7-10 days apart.  Starting on the 5th day after the third immunization, the 
animal was bled of 200 ml daily until the 12th day. During this period, antibody titers to D 
and B antigens reached a peak and then fell off. Since peak titers are present for only a short 
period, daily bleedings are necessary (4). The response of the animals to the immunization 
varied: some developed antibody only to the A antigen, some to the A antigen as well as D or 
B antigens, and some to all three antigens. 
Antiserum specific for the B  determinant was made by absorbing appropriate antiserum 
raised against C3 with aged serum. The aged serum removes antibody to A and D antigens. 
Antiserum specific for the D determinant must start with one raised against C3 containing 
little or no anti-B. This antiserum is absorbed with aged serum heated to 56°C for 1 hr. The 
heating destroys the D antigenic determinant but does not affect the A determinant. 
Antiserum containing antibody only to the A antigen was made by immun~ing as above 
with purified/31A globulin.  Antibody to the A antigen persists for a much longer time in the 
immunized animal than does that to the other two determinants so that the time of bleeding is 
not critical. 
All antisera were checked for specificity by using them for immunoelectrophoretic  analysis 
of fresh, aged, and partially aged serum. All antisera were monospecific in terms of containing 
antibody to only one antigenic determinant of C3.  Some of the antisera  used in this study, 
however, contained trace amounts of antibody to serum proteins other than C3. These were 
not removed as their presence did not interfere with the interpretation of the immunoelectro- 
phoretic patterns. For those studies using immunopolyacrylamide gel electrophoretic analysis, 
the antisera were absorbed so that they contained antibodies to C3 alone. 
Agar  Immunoelectrophoretic Analysis.--The  micromethod of  Scheidegger was used  (6). 
Disodium ethylenediaminetetraacetic acid (EDTA) was added to the agar,  18.6 mg/5 ml of 
agar. 
Preparation of  Immune  Precipitates.--Goats  were  immunized with  purified  crystalline 
bovine serum albumin (BSA)1 obtained from Pentex Biochemical, Kankakee,  Ill.  The BSA 
was incorporated in complete Freund's adjuvant to a  final concentration of 6  mg/ml and 
injected subcutaneously, 1 ml being given at each of 10 sites at each immunization. Goats were 
immunized at weekly intervals for 3 wk and then bled of 800 ml on the 5th and 7th days after 
the third immunization. The equivalence point of the antiserum was determined by the dis- 
appearance of antibody after addition of increasing quantities of B SA. Antibody disappearance 
was detected by using the supernatants of the mixtures to develop the precipitin arc for BSA 
electrophoresed in agar (7). 
The immune precipitates were prepared by adding BSA at equivalence to the antiserum 
after it had been heated to 56°C for 1 hr. The mixture was then diluted with 0.15 ~  NaC1 in 
the amount of 10 ml/ml of antiserum. Mter 30 rain of incubation at 37°C, the immune precipi- 
tate was allowed to stand at 4°C for 16 hr. The precipitate was then centrifuged in the cold, 
washed several times with cold 0.15 M  sodium chloride, and used within a few hours. 
The goat anti-BSA-BSA immune precipitates were also prepared without heating the anti- 
sera but in the presence of 0.02 M EDTA. In addition, in order to prevent a complement reac- 
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tion during the preparation of the immune precipitates, the isolated IgG fraction of goat anti- 
sera to BSA was used as a  source of antibody. To be certain that the results obtained were not 
merely a by-product of the use of goat antibody, antisera to BSA were also prepared in rabbits. 
Finally, two other antigens were utilized in the preparation  of immune precipitates, an isolated 
fraction of human IgG, and ovalbumin. Antibody in these two cases were prepared in the goat 
and guinea pig respectively. Lastly, isolated and purified human IgG was aggregated by pH or 
heat and tested as another agent which would mediate the conversion of C3. In all cases, the 
kinetics of the changes in A, B, and D  antigens of C3, as well as the agar and acrylamide im- 
munoelectrophoretic patterns, were comparable. 
Normal Human Serum.--Blood  was obtained from healthy adult male and female donors, 
allowed to clot at 4°C, and centrifuged at 4°C. The serum was used on the same day it was 
obtained. 
EDTA plasma was prepared by drawing blood directly into a  test tube containing 18.6 mg 
of EDFA/5 ml of blood. 
The Reaction of Normal Human Serum with Immune Prepicitates.--Immune precipitate was 
centrifuged in a calibrated centrifuge tube for 20 min at 2000 g, the supernatant was decanted, 
and the precipitate was broken up by use of a stirring rod and a vortex mixer. After the precipi- 
tate  and  normal human serum  (NHS)  had been  separately warmed  to 37°C,  the  two  were 
mixed in a ratio of 5 volumes of NHS: 2 volumes of packed precipitate and the mixture was in- 
cubated at 37°C for the desired time. The pH remained between 7.0 and 7.4 during the reac- 
tion. The reaction was stopped by immersing the tube in acetone and dry ice. The mixture was 
then allowed to warm to 4°C in ice and the two phases were separated by centrifuging at 4°C. 
By this procedure,  the time interval necessary to reduce the temperature of the reaction  mix- 
ture from 37  ° to 4°C was 6 sec (using glass centrifuge tubes). Freezing the mixtures in the ace- 
tone and dry ice had no significant effect on the conversion products or on the quantitation  of 
their  antigenic  determinants.  The  supernatants  were  either  directly  assayed  or frozen  at 
--70°C and assayed within 24 hr. All time intervals for a  single kinetic experiment were  per- 
formed on the same day using freshly prepared immune precipitates and freshly drawn serum. 
Quantitation  Procedure.--The antigens of C3 were quantitated by the immunoelectrophore- 
fic precipitin method as previously described (7). The procedure however, was modified in some 
instances by omitting electrophoresis of the antigen and employing simple double diffusion of 
antigen and supernatant in agar for detecting the end point in a  manner similar to  that de- 
scribed by Wright  (8).  Both the original method and the double-diffusion modification were 
carried out in Noble agar (Difco Laboratories, Detroit, Mich.) at pH 8.6. All antisera, whether 
used for the original method or for the double-diffusion modification, were standardized so that 
the results were  comparable to  those in previous publications from this laboratory. 
Using this experimental procedure and the immunoelectrophoretic precipitin method or its 
modification for quantitation, the variation of the results on duplicate specimens was less than 
2% for the A and B antigens and 4% for the D  antigen. 
Acrylamide ImmunoeIectrophoretic  Analysis.--Acrylamide  gel, 7.5%,  pH 8.4, was prepared 
according to the method of Davis (9). Samples  2 of 0.1 ml, diluted with 0.15 •  NaC1 to contain 
100-200 #g total protein, were added to the gel at room temperature and electrophoresed for 2 
hr at 7.5 v  and 2 ma per tube. Mter electrophoresis, the entire gel was completely immersed in 
a  test tube containing monospecifie antiserum to one of the three antigens of C3 and allowed 
to soak at room temperature for 18 hr. After removal from the antiserum the gel was soaked in 
0.15 ~  NaCl for 18-24 hr and finally imbedded in Noble agar at pH 8.6.  A  current was then 
passed across the shortest dimension of  the gel for 2 hr to remove unprecipitated serum pro- 
teins. Immune precipitates deposited around the periphery of the gel were rendered visible by 
2 Normal human serum, serum which had reacted with an immune precipitate, aged serum, 
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soaking the gel in standard amidoschwarz stain for several hours and destaining by electro- 
phoresis in 7% acetic acid. Control gels containing serum samples but not soaked in antisera or 
without serum samples but soaked in antisera retained no stain. To document the mobility of 
the breakdown products in the gel, either purified C3 (5) or/~IA (10) were treated as above and 
used as a comparison, or a gel untreated with antibody or stain was cut in 2-3-mm segments, 
each segment was eluted, and the eluted proteins were identified by immunoelectrophoretic 
analysis using monospecific antiserum. To obtain sufficient protein from the gel for identifica- 
tion by immunoelectrophoretic  analysis, several gels had to be eluted and the eluates pooled. 
The elution was accomplished by placing each gel segment in a test tube containing 0.2 ml of 
Veronal-buffered saline, pH 7.4, and grinding it with a  glass rod. After standing for 1 hr at 
room temperature the tube was centrifuged for 20 min, and the supernatants were pooled, 
concentrated by ultrafiltration, and subjected to immunoelectrophoretic analysis. 
It is noteworthy that with electrophoresis of EDTA plasma in 7.5% acrylamide gels, each 
of the monospecific antisera to the three determinants of C3 produced only a single band, al- 
ways with the same mobility, thus indicating that,  within the limits of detection by  this 
method, the antisera were indeed monospecific.  In addition, gels electrophoresed to remove 
ammonium persulfate before the sample was applied gave the same relative patterns as those 
gels  which  contained ammonium persulfate. The  only  observable difference was  that  the 
mobility of all proteins was slightly faster when the persulfate was removed. In contrast, if 
purified C3 or its conversion  products rather than serum were applied to the gel, the ammonium 
persulfate interfered. With persulfate present, an extra band often appeared which was just 
anodal to native C3.  For this reason, when purified C3  or isolated products were used, the 
ammonium persulfate had to be removed before application of the sample. 
Acid polyacrylamide gels, 6%, were prepared at pH 4.5 by the method of Reisfield  et al. 
(11). Ammonium persulfate was always removed before application of the sample. 
When the mobilities of proteins were compared on separate polyacrylamide gels, the samples 
were always electrophoresed  under identical conditions, i.e. in the same run, side by side, and 
for the same length of time. A tracer dye, bromphenol blue, was always utilized and the dis- 
tance it traveled in each gel was carefully measured as an added control. No gels were com- 
pared unless the tracer dye in each migrated the same distance. 
EDTA plasmas from many normal individuals were tested as a  source of C3.  All gave a 
single, discrete band on gel with each antiserum. Although the allotypes of C3 were not deter- 
mined for the human serum, it was felt that the above controls eliminated the possibility of an 
allotypic form of C3 being misinterpreted  as a conversion product. Kinetic and immunoelectro- 
phoretic results were not affected by the source of the serum. 
Aging of Serum.--Normal human serum was "aged" by incubating at 37°C for 7-14 days 
(12). To prevent bacterial contamination, sodium azide, sodium fluoride,  or chloramphenicol 
was added at a final concentration of 5 X  10  -3 M. Results by all three methods of preservation 
were identical. 
Reaction of Trypsin with Normal Human Serum.--Trypsin,  3 0.1 ml of a solution containing 
10 mg/ml, was added to 0.25 ml of normal human serum for either 60 see at 20°C, 60 min at 
37°C, or 4 hr at 37°C. The reaction was stopped in each case by adding 2 mg of soybean trypsin 
inhibitor and then immediately subjecting the mixture to agar or acrylamide immunoelectro- 
phoretic analysis. 
Preparation of Purified Complement  Components.--Guinea pig C 1 and C2 were "functionally 
purified" by a modification of methods previously described (13, 14). 
Human C3 was partially purified by the method of Nilsson and Mtiller-Eberhard (5). The 
3 From bovine pancreas,  type  III,  two  times  recrystallized, dialyzed,  and  lyophilized; 
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resultant C3 product contained at least three additional proteins by acrylamide gel electropho- 
retic analysis, none of which was a C3 breakdown product. 
Preparation of C3i.--EACIGP,4Hu,2Gr  in a concentration of 1 X  10  o cells/ml were prepared 
by the method of Borsos and Rapp (15). Purified C3 in a concentration of 1.5 mg of total pro- 
tein/ml was added and the mixture was incubated at 37°C for 30 min. The cells were then cen- 
trifuged and  the supernatant,  which contained  unreacted  native C3  and  C3i,  was  concen- 
trated 10-fold by ultrafiltration. 
Preparation of C3a and C3b.--Trypsin, 1.0 ml of a solution containing 0.1 #g/ml, was added 
to 5 ml of purified C3 containing 10 #g of protein for 60 sec at 20°C.  1 ml of soybean trypsin 
inhibitor at a concentration of 0.2 #g/ml was then added and the mixture acidified to pH 3.6 
by the addition of 1 N HCI. After concentration by ultrafiltrafion, the mixture was passed over 
a 90 X  2.5 cm column of Sephadex G-100 (Pharmacia Fine Chemicals Inc., Uppsala, Sweden) 
and eluted as described by Bokisch et al.  (3). Both C3a and C3b were concentrated by lyo- 
philization. In addition, the ultrafiltrate from the above mixture before Sephadex filtration was 
lyophilized and found to contain small amounts of C3a. 
C3a  was  also prepared  by reacting hydroxylamine with purified C3  or euglobulin  (16). 
Hydroxylamine hydrochloride was added to euglobulin in a 0.1 ~ phosphate solution, pH 6.8, 
to a final concentration of 0.3 u. The pH was readjusted to 6.8 by the addition of a solution of 
Na2HPO4 • After 45 min at room temperature, 2 vol of 0.1 N ammonium acetate buffer (pH 
3.6) were added and the final pH was adjusted to 3.6 by 1 3~ acetic acid. This mixture was then 
ultrafiltered and the ultrafiltrate was lyophilized, dissolved in a small volume of 0.15 ~ NaC1, 
and put on a 1 X  6 cm G-25 column equilibrated with a 0.0175 ~ phosphate solution, pH 6.3, 
to remove excess salts. 
Finally, C3a and C3b were formed by acidifying C3i (prepared as above) to pH 4.0 with 0.1 
HC1 (17) followed by separation on acid polyacrylamide gel. 
In all assays,  C3a was detected after electrophoresis on polyacrylamide gel at pH 4. Identifi- 
cation was by reaction with antibody to the B antigen of C3. C3b was detected on both pH 4 
and pH 8.7 gels and C3i only on pH 8.7 gels. 
RESULTS 
Changes  in  the  Agar  Immunoelectrophoretic  Characteristics  and  Antigenic 
Structure of C3 During the Reaction  of Normal Human Serum with an Immune 
Complex.--Native  C3  may  be  characterized  by  its  typical  electrophoretic 
mobility  in  agar  and  by  the  presence  of  three  major  antigenic  determinant 
groups,  previously  designated  A,  B,  and  D  (4).  Both  of  these  characteristics 
are illustrated in Fig.  1. As C3 in normal human  serum reacts with an immune 
precipitate,  these characteristics change in a  consistent and predictable manner. 
In general  terms,  the molecule of C3  appears  ultimately  to be cleaved into at 
least  two  distinct  breakdown  products,  one  bearing  the  A  antigenic  deter- 
minant,  designated  C3c,  and  the  other,  the  D  determinant,  designated  C3d. 
The  B  antigen,  which  was  present  on  the  intact  molecule,  disappears.  These 
changes  are  shown  by  the  immunoelectrophoretic  patterns  of  serum  after 
reaction with  an  immune precipitate for 3  and  15  rain  (Figs.  2,  3).  It appears 
that  C3c  and  C3d  have  slightly  faster  mobilities  than  native  C3.  That  C3c 
and  C3d are separate  and distinct proteins is indicated  by the double spurring 
shown in Fig. 4. 
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serum  reacted  with  an  immune  precipitate  and  a2D  present  in  aged  serum 
have  different  appearances  upon  immunoelectrophoretic  analysis  in  agar. 
There appears to be a greater heterogeneity of a2D suggesting two populations 
Fla. 1.  Agar immunoelectrophoretic analysis of EDTA normal human plasma illustrating 
the three major antigenic determinants  of C3. 
Fro, 2. Agar immunoelectrophoretic analysis of human serum which has reacted for 3 min 
at 37°C with an immune precipitate. 
of molecules, one with a faster mobility in addition to one of the same mobility 
as C3d. This  difference,  though small,  has been  consistent in  all  experiments. 
On  the  other hand,  C3c is  similar  in  electrophoretic  mobility to/31A in  aged 
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Based on criteria previously established (4),  C3i, the fluid-phase conversion 
product of the reaction of purified C3 with  C4,  2, has not been identified as a 
product  of  the  reaction  of  an  immune  precipitate with  fresh  normal  human 
serum.  If  C3i  were  present  as  a  prominent  breakdown  product,  since it is  a 
FIG. 3.  Agar immunoelectrophoretic  analysis of human serum which has reacted for 15 rain 
at 37°C with an immune precipitate. 
Fro. 4.  Agar immunoelectrophoretic  analysis of human serum which has reacted for 15 min 
at 37°C with an immune precipitate. The additional arcs are due to proteins which have pre- 
cipitated with small amounts of contaminating antibody in the antisera to C3. These arcs have 
been rendered visible because diffusion has proceeded for 48 hr. 
single protein containing both A  and D  antigens (4),  there would be no spur- 
ring of precipitin bands made separately with antisera to the A  and D  antigens 
as shown in Fig. 4  for C3c and C3d. 
Characteristics of C3 Fluid-Phase  Conversion Products in A crylamide Gel.- 
Whereas  immunoelectrophoretic  analysis  in  agar  of  serum  reacted  with  an 
immune  precipitate showed  that  only two  breakdown  products  are liberated 
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other conversion product. After the first 30 sec of reaction, there appeared in 
the  fluid  phase  a  protein  which  was  antigenically  intact  but  which  had  a 
slightly faster mobility than  native  C3  (Fig.  6).  This protein was relatively 
stable and persisted in the fluid phase for as long as 1 hr at 37°C. Because it 
was similar to native C3, reacted with antibody to three antigens, A, B, and D, 
and  did not  appear  to  be  a  cleavage product,  it  was  given  the  designation 
C3x. As will be reported in  a  subsequent communication, a  protein with the 
same  characteristics  as  C3x in  the fluid phase  may also be  eluted  from the 
immune precipitate. 
FIG. 5.  Comparison of the agar immunoelectrophoretic patterns of serum which has re- 
acted for 15 min at 37°C with an immune precipitate (above) and aged serum (below). 
Acrylamide immunoelectrophoretic analysis  of  the  fluid  phase  delineated 
two  other important features of the  C3  conversion products  (Fig.  7). As  in 
agar, the product bearing the D  antigen (C3d) had  a slower mobility than did 
a2D in aged serum. In contrast, however, while the mobilities of C3c and/~IA 
were similar in agar, in polyacrylamide gel the conversion product bearing the 
A antigen (C3c) had a slower mobility than did/~IA in aged serum. Again no 
protein corresponding to C3i was identifiable in the fluid phase. 
Characteristics of C3i.-C3i,  formed  by  the  reaction  of  purified  C3  and 
EAC1, 4, 2, reacts with antibody to the A  and D  antigens of native C3 but,  as 
noted  in  a  previous publication  (4),  not  with  antibody  to  the  B  antigenic 
determinant.  Observations made in  the present study indicating the absence 
of the B determinant are listed below: (a)  C3i reacts  only with  antisera  to A 
and D  antigens by immunoelectrophoretic analysis in  agar.  (b)  A  band  cor- 
responding to C3i can be developed on an acrylamide gel only by the use of 
antisera to A and D  antigens and not by antisera to the B determinant. (c) On 664  ALTERATIONS OF  SERUM C3  IN  IMMUNE REACTIONS 
agar immunoelectrophoretic analysis of a  mixture of C3 and C3i, the arc repre- 
senting C3  may be seen to spur through that for C3i  when using a  combined 
anti-A, B,  and D  antiserum. This is due to  the fact that  C3  reacts with anti- 
body to the B  antigen while C3i does not. There is no spurring when antisera 
FIG. 6.  Comparison  of  acrylamide  immunoelectrophoretic patterns  illustrating  C3  in 
ED FA serum and C3 and C3x in a serum which had reacted with an immune precipitate for 1 
min. These gels have been developed in antibody to the A antigen of C3. C3 and C3x would 
also be visualized in the same pattern with antibody to the B or D antigens of C3. C3c is not 
visualized in the gel to the right because the antisera to the A antigen had to be diluted several- 
fold in order to clearly illustrate C3x.  This was necessary because C3x is present in much 
smaller amounts than C3c at this time interval. 
FIG. 7.  Acrylamide immunoelectrophoretic patterns of fluid-phase C3 conversion products. 
The gels to the left of center have been developed with antibody to the A antigen; those to the 
right with antibody to the D  antigen. The center gel contains unreacted EDTA plasma; on 
either side of the center gel are gels containing serum reacted for 15 min with an immune precip- 
itate; the outer gels contain aged serum. When antibody to the B  antigen is used to develop 
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to only A  and D  antigens are used.  (d)  When all of the material reacting with 
anti-B  is  absorbed  from  a  mixture  of  purified  C3  and  C3i  by  monospecific 
antiserum,  agar  immunoelectrophoretic  analysis  of  the  resultant  solution 
reveals a  protein with the mobility of C3i which reacts  only with antibody to 
A  and D  antigens. 
C3i has a  similar electrophoretic  mobility in agar  to  that  of  C3x.  In  acryl- 
amide gel the mobilities of C3i and C3x also are very nearly the same. In numer- 
FIO. 8.  Acrylamide immunoelectrophoretic analysis of C3, C3i, C3x, and C3b. The gel to 
the left contains the fluid phase of the reaction of purified C3 and EAC4, 2. The gel in the center 
contains serum which has reacted for 3 rain with an immune precipitate. The gel on the right 
contains the end product of the reaction of euglobulin and hydroxylamine. All gels have been 
soaked  in antibody to the A antigen. C3c is not visualized in the center gel for  the reason 
enumerated in the legend of Fig. 6. 
FIo. 9.  Acrylamide immunoelectrophoretic analysis of the same samples as in Fig. 8. How- 
ever,  the gels have been developed  in antibody to the B  antigen. Only native C3 and C3x 
visualize, since C3i and C3b do not consume antibody to the B antigen. 666  ALTERATIONS OF  SERUM  C3  IN  IMMUNE  REACTIONS 
ous determinations, however, there was a consistant and reproducible difference, 
C3x always having a  slightly faster mobility than C3i (Fig. 8). Nevertheless, 
the major point of difference between the two proteins rests with the fact that 
C3i  does not  consume antibody to  the B  antigen,  which  C3x  does  (Fig.  9). 
Characteristics  of C3b.--C3b was produced in the fluid phase by the reaction 
of purified C3  with trypsin (3)  or hydroxylamine (16), or by the acidification 
of C3i (17). In all of the above situations,  C3b, like C3i, consumed antibody 
to the A and D  antigens of native C3 but not to the B antigenic determinant. 
This has been inferred from the following: (a)  C3b reacts only with antisera 
to  the A  and  D  antigens  by immunoelectrophoretic analysis  in  agar.  (b)  A 
band corresponding to C3b can be developed on an acrylamide gel only by tile 
use of antisera to A and D  antigens and not by antisera to the B determinant. 
TABLE I 
Comparison of C3 Conversion Products 
Product  Demonstrable  Mol wt 
antigens 
C3  A, B, D  235,000 (3) 
C3x  A, B, D  ? 
C3i  A,  D  ? 
C3a  B  8,700  (3) 
C3b  A, D  223,000 (3) 
C3c  A  151,000 (3) 
C3d  D  27,000 (3) 
/31A  A  150,000 (25) 
a2D  D  70,000 (25) 
(c) When C3b is quantitated for the A, B, and D determinants by the immuno- 
electrophoretic precipitin method,  consumption of antibody to  the A  and D 
antigens can be demonstrated; there is no consumption  of antibody to  the  B 
antigen. 
C3b and C3i not only seem to have the same antigenic configurations, but 
also identical electrophoretic mobilities in agar. By analysis in polyacrylamide 
gel, however, C3b has a faster mobility than C3i. In addition, C3b also has a 
faster mobility in  acrylamide gel than  does C3x. 
The major differences in C3x, C3i, and C3b are illustrated in Figs. 8 and  9. 
Fig. 8 illustrates the relative polyacrylamide gel mobilities of the three proteins. 
Fig. 9 shows that C3x differs from C3i and C3b by consuming antibody to the 
B  antigen.  A  sununary  of some  of  the  characteristics  of  the  C3  conversion 
products may be found in Table I  and Fig. 10. 
Characteristics  of C3a.--C3a,  whether produced by the reaction  of  trypsin 
(3) and purified C3 or hydroxylamine (16) and purified C3, has a characteristic 
mobility on acid polyacrylamide gel. As illustrated  in  Fig.  11  and  described FIG. 10.  Schematic drawing illustrating the relative mobilities of  C3  and  its  conversion 
products on polyacrylamide gel. 
FIo. 11.  Acrylamide immunoelectrophoretic analysis of C3a. The C3a was produced by the 
reaction of hydroxylamine and euglobulin.  The gel has been developed in antibody to the B 
antigen of C3. 
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previously by Bokisch  et  al.  (3),  it  has  a  marked  cathodal  migration.  C3a 
contains  only  the  B  antigen  as  demonstrated  by  the  following:  (a)  A  band 
corresponding to C3a may be developed on an acid gel only by antisera to the 
B  antigen. (b)  C3a consumes antibody only to the B  antigen and not to A  and 
D antigens. Similar results have been obtained using highly purified C3a derived 
from trypsin-reacted C3 kindly provided by Dr. H. J. Miiller-Eberhard. 
Reaction  of Trypsin with Normal Human Serum.--When  trypsin is  allowed 
to react with normal human serum at 20°C  for 60  sec  (3),  the  product,  sub- 
jected to agar immunoelectrophoretic analysis, reacts with the A and D antigens 
to  produce  arcs  resembling  those  produced  by  C3c  and  C3d  (Fig.  12).  On 
FIG. 12.  Agar immunoelectrophoretic  analysis of trypsin-treated normal human serum at 
20°C for 60 sec. The original serum is shown above. 
acrylamide  immunoelectrophoretic  analysis,  however,  the  trypsin-produced 
C3c and C3d have slightly faster mobilities than those products obtained when 
fresh normal human serum reacts with C4, 2 on an immune precipitate. C3b was 
not  found,  even  under  these  mild  conditions,  in  contrast  to  the  study  by 
Bokisch et al. (3). If the incubation is continued for 1 hr at 37°C, J31A and a2D 
are generated, as well as C3c and C3d. After 4 hr at 37°C, all of the A  antigen 
may be found on ¢31A and all of the D  antigen on a2D  (Figs. 13, 14). 
Fluid-Phase Kinetics of the B Antigen of Native C3.--As indicated in previous 
sections, the B  antigenic determinant is demonstrable on native C3 as well as 
on  two conversion products,  C3x  and  C3a.  Quantitatively,  however,  as fresh 
normal human serum reacts with an immune precipitate at 37°C, the consump- 
tion of antibody by the B  antigen decreases as native C3 is converted to C3a 
and  C3x. This decrease in  antibody consumption is, in large part,  due  to the 
fact that  the B  antigen  of C3a is unavailable for combination with  antibody SPITZER~  STITZEL,  PAULING,  DAVIS,  AND  WEST  669 
and that  C3x has fewer B  determinant groups  than C3.  The kinetics of  this 
reduction of antibody consumption are illustrated in Fig. 15 and are a measure 
of  the  rate  of  the  conversion of  native C3.  A  control curve illustrating the 
FIG. 13.  Agar immunoelectrophoretic analysis of trypsin-treated  normal human serum at 
37°C for 4 hr is shown in the center panel; the original serum is shown above and below. 
FIG. 14.  Agar immunoelectrophoretic analysis of trypsin-treated  normal human serum at 
20°C for 60secisshown above. Serum which has reacted with trypsin for  4hrat 37°C is shown 
below. 
alterations in the B  antigen of C3 as EDTA normal human serum reacts with 
an immune precipitate is included in Fig. 15. In the presence of EDTA there is 
no possibility for the formation or binding of C3 convertase and consequently 
no change in  the  B  antigen or  conversion of  C3.  It  is  evident that,  under 
conditions where C3 convertase is able to form, consumption of antibody to the 670  ALTERATIONS  OF SERUM  C3  IN  IMMUNE  REACTIONS 
B  antigen  decreases  rapidly,  the  reduction  amounting  to almost  50%  in  the 
first  60  sec. 
These same data are illustrated  in Fig.  16 but are expressed  as the per cent 
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FIG.  15.  Kinetics of the B antigen in the fluid phase as normal human serum reacts with an 
immune precipitate at 37°C. A control curve with EDTA present in a  final concentration of 
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Fro. 16.  Per cent of initial C3 converted during the reaction of normal human and an im- 
mune precipitate. 
of initial  B  antigen  or C3 input  that is  converted. It is  to be noted  that  the 
work with  acrylamide gel electrophoresis  indicates  that  the B  antigen  which 
will consume antibody at any given time in the fluid phase is a  summation of 
the B antigen on unreacted C3 as well as that contained on C3x. It has not yet 
been  possible  to  quantitate  these  two proteins  separately  so  as  to  obtain  a 
more precise determination  of the conversion of the native molecule. SPITZER,  STITZEL,  PAULING,  DAVIS,  AHD  WEST  671 
Kinetics o/the Fluid-Phase A  and D Antigens  of C3.--As serum reacts with 
an immune precipitate, the A antigen originally present on native C3 may be 
found  on  three  different  conversion  products,  C3x,  C3b,  and  C3c.  C3x  is 
present in the fluid phase as well as bound to the immune precipitate;  C3b is 
only present in  the bound phase, while C3c is only found in the fluid phase. 
Similarly,  the D  antigen,  originally present  on native  C3,  may be found  on 
C3x,  C3b,  and  C3d.  C3d,  like  C3c,  is  only present  in  the  fluid  phase.  The 
fluid-phase measurements of the  total A  and D  antigens  at  any given  time, 
therefore, reflect the kinetic changes in  each of these proteins. The results of 
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FIo. 17.  Kinetics of the A and D antigens in the fluid phase as normal human serum reacts 
with an immune precipitate at 37°C. 
such  measurements may be seen in  Fig.  17.  It is  clear  that in  the  first few 
minutes of reaction the values for both A  and D  antigens  in  the fluid phase 
decrease in amounts corresponding to 20 % for the A and 10 % for the D antigen. 
This  decrease  corresponds  to  the  deposition  of C3  products  on  the  immune 
precipitate.  Despite the fact that  deposition  continues  for nearly 5  min  (18, 
19), 4 however, the amounts of fluid-phase A and D  antigens do not continue to 
decrease. This reflects the fact that as C3 is activated, only a small percentage 
of the  activated molecules are deposited,  the remainder cleaving in  the fluid 
phase.  As  cleavage occurs,  the  number  of  antigenic  sites  increases  but  to  a 
lesser extent than when serum ages (12). This increase accounts for the rise in 
4 Spitzer, R. E., and A. E. Stitzel. The antigenic and molecular alterations of the third 
component of human complement during an immune reaction. Demonstration of two deposi- 
tion products from normal human serum. Manuscript in preparation. 672  ALTERATIONS  OF  SERUI~  C3  IN  IMMUNE  REACTIONS 
value for fluid-phase A and D  antigens before deposition ceases at about 5 min. 
After  5  rain  of reaction,  the  increase  in  the  amount  of A  and  D  antigens  is 
more  than  would  be  expected  from  cleavage  of  native  C3  and  presumably 
reflects the removal of bound C3 by serum factors and its subsequent  cleavage 
in the fluid phase (t8,  19).  4 
Aging  of  C3  and  C3x.--Normal  human  serum  which  had  reacted  with  an 
immune precipitate  for 3  rain was separated  by centrifugation  and allowed to 
age for 7-14 days at 37°C. The B  antigen  concentration at  the onset of aging 
was  15  units/ml.  From  previous  work  (12),  it  would  be  expected  that  with 
aging,  if  that  protein  containing  the  B  antigen  in  the  fluid  phase  were  truly 
native  unreacted  C3,  there  would  be  loss  of  the  B  antigen,  an  increase  in 
TABLE II 
Effect  on Antibody Consu,  mption to Determinants  of C3 with Aging of Serum Previously  Reacted 
with an Immune Precipitate  at 37°C for 3 Min 
Before aging  After aging  Expected after  Actual increase 
aging 
units/mi  units/ml  units/ml  % of expected* 
B antigen  15~  0.0  0.0  -- 
A antigen  19.2  23.5  32.7  31 
D antigen  19.5  17.6  42.0  0 
* The expected number  of units  after  aging was calculated  by ascertaining  the units  of 
A or D antigen as C3 at the onset of aging and multiplying by factors expressing the amount 
of expansion that is obtained with the same serum when it is aged without prior reaction with 
an immune precipitate  (12). 
:~ The serum used for the experiment  had an unusually  high C3 concentration;  for this 
reason, the concentration  of B antigen  after  3 min of reaction is higher than that shown in 
other experiments (Figs. 16, 17). 
antibody consumption to the A and D  antigens,  and the resultant formation of 
/31A  and  o~2D. In  15  separate  experiments,  however,  all  supernatants  upon 
aging  showed  little  or no  change  in  antibody  consumption  by the  A  and  D 
antigens as the B  antigen disappeared  (Table II). Acrylamide immunoelectro- 
phoretic  analysis  of the  aged supernatant  identified  the A  antigen  containing 
protein  as/~IA  and  the  D  antigen-bearing  product  as C3d.  No  C3c  or cx2D 
were present.  Thus, it appears that  the native C3 molecules have been altered 
by brief contact with  an immune precipitate,  so that  upon aging they fail  to 
expose additional  antigenic sites.  In addition,  this alteration prevents cleavage 
of the molecule in the usual fashion so that  the products obtained upon aging 
are ~IA and  C3d.  It is  noteworthy  that  the  C3x present  in  the  supernatant 
before  aging  also  disappeared.  It  must  therefore  be  assumed  that  C3x,  on 
aging, also does not expose additional  antigenic sites. 
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C3x, C3c, and C3d, while after the aging only/~IA and C3d could be identified, 
the following conclusions  can also be inferred:  (a)  Altered C3  and C3x must 
convert to/~IA and C3d upon aging. (b)  C3c must convert to ~IA upon aging. 
(c)  C3d is not altered by the aging process. 
Heat  Stability  of C3  and C3x.--Normal  human  serum  which  had  reacted 
with an immune precipitate for either 30 sec or 3 rain at 37°C, was centrifuged 
and then heated to 56°C for 60 min. The B antigen present in the reacted serum 
completely disappeared and  C3c and  C3d were produced.  In contrast,  if un- 
reacted normal human serum is heated  to 56°C  for 60 rain,  the B  antigen is 
reduced by only 30% and a small amount of C3c and C3d is generated. These 
data are illustrated in Table III and suggest that the heat stability of native C3 
in human serum has been grossly altered by a  brief contact with  an immune 
precipitate. 
TABLE  III 
Effect of Heating on B  Antigen  of C3 in Normal Serum and in a  Serum Reacted with an 
Immune Precipitate 
B antigen before  B antigen after 
heating  heating*  Decrease 
units/ml  units/ml  % 
Normal human serum  30  21  30 
30 sec reacted serum:~  18  <0.5  100 
3 rain reacted serum:~  7.5  <0.5  100 
* 56°C for 60 min. 
~: Serum previously reacted with an immune precipitate at 37°C for either 30 sec or 3 rain. 
DISCUSSION 
The use of monospecific antisera to each of the three major antigenic deter- 
minants of C3 provides an investigative tool which allows identification of the 
products of the in vitro conversion of serum C3 without interference from other 
serum proteins.  Breakdown  products  produced  in  a  variety of ways may be 
identified  by  their  reaction  with  specific  antibodies  after  electrophoresis  in 
agar or acrylamide gel. The present study has dealt mainly with the products 
of C3  found in the fluid phase when  the  C3  in normal human serum ages or 
reacts  with  C3  convertase  or  trypsin.  Of  interest  are  the  differences in  the 
breakdown products produced in serum as compared with those found in the 
reaction with purified complement components. While the use of the C3 anti- 
genic determinants affords a  sensitive means to define these products,  certain 
deficiencies  still  exist,  the  resolution  of  which  must  await  better  analytical 
techniques. 
C3, whether in purified form or in normal human serum, can be defined as a 
protein  bearing  three  antigenic  determinants,  A,  B,  and  D,  with  distinctive 674  ALTERATIONS  OF  SERU1VI  C3  IN  IMMUNE  REACTIONS 
electrophoretic  mobilities  in  agar  and  acrylamide  gel.  When  purified  C3  is 
reacted with isolated C4, 2,  C3 is converted to C3i which reacts only with the 
A and D  antigens (4)  and exists only in the fluid phase (20). In addition to the 
apparent  absence  of  the  B  antigen,  C3i  differs from native  C3  by having  a 
faster electrophoretic mobility in agar, a greater number of available sulfhydryl 
bonds, and an s~0 rate of 9.0 as compared to 9.5  for C3  (1,  20,  21). Reasoning 
from this data, it would be expected that the formation of C3i from C3 would 
entail the loss of a  small fragment. None, however, has been demonstrated (1, 
20,  21). Thus, it is necessary to assume a  change in conformation with a  loose 
complex of C3a and C3b, rather than complete cleavage of C3 as C3i is formed. 
Further evidence to support this view is the fact that when C3i is acidified to 
pH 3,  a  small basic fragment known as C3a dissociates (17,  22). C3a has been 
shown to bear at least one antigenic determinant in  common with native C3 
(3), which in the present study has been documented as the B determinant. It is 
clear  that  the  B  antigen  must  also  be  present  on  C3i  but  unavailable  for 
combination  with  antibody  by virtue  of  the  configurational  change  in  the 
molecule. 
The portion of the C3i molecule remaining after dissociation of C3a in acid 
is  known  as  C3b  (20).  Despite  the  loss  of  C3a  which  has  an  approximate 
weight of 10,000  (3),  the s20 rate of C3b is essentially the same as C3i  (3). It 
also consumes antibody to the same antigenic determinants, A and D, and has 
the same electrophoretic mobility in agar as C3i. By electrophoretic analysis in 
acrylamide gel, however, C3b may be shown to be distinct from C3i. C3b may 
also be found on an erythrocyte, after the reaction of C3 and EAC 1, 4, 2 at neutral 
pH  (20),  and  is  the  only form of bound  C3  which  may be obtained in  pure 
systems (23). The C3b under these conditions appears to be identical with the 
C3b formed from C3i at low pH (20). 
The present study indicates  that when human serum is used as a  source of 
complement,  the  reaction  of  C3  with C4, 2  produces somewhat different  con- 
version products. Foremost, C3i is not identifiable in the fluid phase. Whether 
it is simply never produced or is rapidly degraded by serum factors, as intimated 
by Miiller-Eberhard  (24),  is not known. Not only is C3i not identifiable, but, 
in addition, its breakdown products, C3a and C3b, have not been found in the 
fluid phase. Furthermore,  C3a functional activity, i.e.  anaphylatoxin activity, 
has  been reported  to  be minimal or  absent when  the  complement system in 
human serum is activated (3). This inability to demonstrate  C3a or C3  ana- 
phylatoxin activity in  serum may be due  to a  number of factors.  C3i, if it is 
formed, might be degraded in such a fashion that C3a is simply not generated; 
alternatively and more likely, if C3i is cleaved so that C3a is formed, the C3a 
may be rapidly inactivated by the  C3a inactivator present in normal human 
serum  (3).  In  an  effort to demonstrate  C3a,  the  pH of a  reacted serum was 
lowered to 3.2. If C3a were generated, the increased HsO  + concentration would SPITZER, STITZEL, PAULING, DAVIS, AND WEST  675 
facilitate its liberation and at the same time block the action of the C3a in- 
activator, as described by Bokisch et al. (3). Unfortunately, below pH 5 the B 
antigenic determinant is rendered partially unreactive so its presence cannot be 
clearly demonstrated by this maneuver. 
As will be shown in subsequent publications  (19),  4 C3b,  while absent from 
the fluid phase, is, nonetheless, found in the solid phase. It may be eluted by 
EDTA  Veronal-buffered saline  from  an  immune  precipitate,  and  from  this 
source shows the same antigenic configuration and electrophoretic mobility in 
agar as  C3i formed in pure systems.  C3b may be differentiated from C3i by 
its mobility on polyacrylamide gel. 
In  the present study,  a  new conversion product which is not C3i,  C3a,  or 
C3b has been found in the fluid phase,  as well as on the immune precipitate 
(18, 19). 4 This conversion product has been designated C3x. C3x, like C3, bears 
all three antigenic determinants but differs from it in that C3x has a  slightly 
faster mobility in both agar and polyacrylamide gel. It differs from C3i  and 
C3b in its antigenic configuration, in its electrophoretic mobility in acrylamide 
gel, and in its stability in serum. Additional data to be presented subsequently 
amply  support  these  differences (19). 
C3x has not been found  when purified C3 reacts with EAC4, 2. The qualitative 
data of this paper do not allow assumptions as to the origin of C3x. However, 
further work (18, 19) strongly suggests that C3x is a product of a  serum con- 
version  system  unrelated  to  C3  convertase  and  has  considerable  biologic 
activity. 
Finally, two proteins considered to be the counterparts of ~IA and a2D  in 
aged  serum  have  been  found  in  the  fluid  phase.  These,  by  World  Health 
Organization nomenclature (25),  are designated C3c and  C3d. Whether they 
are formed directly from native C3, arise from C3x, or are degradation products 
of unstable fluid phase C3b, is not clear. C3c clearly differs from ~IA and C3d 
from a2D, although they bear exclusively the A  and D  antigens respectively. 
By mobility in  agar,  C3d most resembles the a2D  found when fresh human 
serum reacts with hydrazine (4). C3c and C3d are similar but not identical to 
the  trypsin-generated fragments  of  the  same  designations.  A  comparison  of 
the  C3  conversion products both  in  isolated  systems  and  in  serum may be 
found in Table I  and Fig.  10. 
The products of the reaction of trypsin and normal human serum appear to 
occupy a middle ground between those produced when C4, 2 reacts with C3 in 
serum and those produced by the aging of serum. At short incubation times, 
C3c and C3d are liberated; with longer times 151A and a2D are formed. Whether 
~IA and a2D are further breakdown products of C3c and C3d or direct cleavage 
products of C3  by trypsin is  not known.  As noted above, the C3c and  C3d 
generated by trypsin are slightly different in their electrophoretic mobilities in 
acrylamide from the C3c and C3d generated by C4, 2 in serum. These differences 676  ALTERATIONS OF SERIY~ C3 IN IM2~UNE REACTIONS 
in mobility are not totally unexpected. The data of Bokisch et al.  (3), for the 
differences in  C3a produced by trypsin and C4, 2,  lead one to suspect different 
cleavage points in a relatively select area of the C3 molecule. The observation 
that the C3c and C3d produced are also slightly different supports this view. 
The kinetic data for B  antigen  disappearance indicate  that  C3  breakdown 
occurs very rapidly upon  addition  of an immune precipitate  to fresh human 
serum. Judging by the loss of the B  antigen, 50 %  of the  C3  is converted in  1 
min and over 90 % by 60 min. It is to be emphasized that these are at best only 
minimum values since a portion of the B  antigen quantitated in the fluid phase 
is  present  as  C3x,  which  in  itself  can  be  considered  a  conversion  product. 
Moreover,  acrylamide gel studies  of the fluid phase after  15  rain  of reaction 
with an immune precipitate indicate  that most, if not  all,  of the B  antigen- 
bearing protein is C3x. Hence, it appears that native C3 is converted to another 
form very rapidly after the immune precipitate addition. 
Of greater interest is the fact that even before it is converted to C3x, the C3 
molecule appears to be altered by the presence  of  the  precipitate.  There are 
two observations which reveal this alteration. First, within 3 min after addition 
of  the imnlune precipitate  to human serum,  the native C3  remaining uncon- 
verted is changed by the precipitate so that it does not age in vitro in the same 
manner  as  does  C3  which  has  not  contacted  a  precipitate.  Previous  reports 
(12)  have indicated that when serum containing native C3 is allowed to age in 
vitro,  the formation of jS1A and a2D  result in the consumption of more anti- 
body to A and D  antigens than did the native C3. Thus, with aging, antibody 
consumption to the A  antigen increases by a factor of 1.6-1.8 and that to the 
D  antigen by 2.5-3.0.  It would be predicted from this data that serum which 
has  reacted  with  an  immune precipitate  for  a  short  time  and  still  contains 
native unreacted C3, would,  on aging, demonstrate an increased consumption 
of  antibody  to  A  and  D  determinants  as  ~IA  and  a2D  were formed.  This, 
however, was not observed. Antibody consumption to the A and D  antigens as 
shown  in  Table  II did  not  increase,  or  increased  much  less  than  would  be 
predicted from experience with aged serum. Further,  with aging,  the ultimate 
breakdown products are ~IA and C3d rather than ~IA and c~2D. This observa- 
tion indicates that the course and characteristics of C3 breakdown produced by 
aging are materially modified by the addition for a 3-min period of an immune 
precipitate  to  the  serum. The second point  of  evidence indicating  a  primary 
change in C3 is provided by the comparison of the heat stability of native C3 
and  the  C3  remaining  after  reaction  of normal  serum with  an  immune  pre- 
cipitate for as short a  time as 30 sec. When human serum so treated is heated 
to  56°C  for  1 hr,  the  B  antigen  of  C3  is  completely destroyed.  In  contrast, 
when unreacted  serum is heated  to 56°C  for  1 hr  there  is minimal reduction 
in the B antigen of C3. These observations would indicate that the C3 molecule, 
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quickly  undergoes  a  distinct  alteration  when  in  contact  with  an  immune 
precipitate manifested by a  change in its reactivity with respect to aging and 
with respect to its heat lability. 
Finally, although the fluid-phase kinetics of the A and D  antigens represent 
a  complex  situation,  their  consideration  reveals  an  important  concept.  The 
data of Miiller-Eberhard et al. (1), for the reaction of purified C3 with isolated 
C4, 2,  indicated  that  the ratio of  converted  C3  to bound  C3  was relatively 
constant  throughout  the reaction period.  If the  same were true when  serum 
reacts with an immune precipitate, one would expect that as long as deposition 
were proceeding the amount of A or D  antigen in the fluid phase would either 
slowly decrease in a manner analogous to the B antigen or increase if the unfold- 
ing of new antigenic sites during cleavage were very great. However, as illus- 
trated in Fig. 17, there is a diphasic curve in the first 4 min when deposition is 
occurring, implying that in serum the ratio of converted to bound  C3  is not 
constant. Presumably, this lack of constancy is the result of the fact that C3 is 
converted and bound both as C3x and C3b (18,  19). 4 
It is quite clear that the conversion products of C3 resulting from the reaction 
of an immune precipitate with normal human  serum are more complex than 
previously thought.  By the same token it is equally clear that  the reactions 
observed using purified complement components may not always be indicative 
of those that occur in the milieu of serum. The differences appear to be more 
than minor. As one example, C3x seems to represent a major conversion product 
of  C3  that  is  not  generated  with  purified  complement  components  but  is 
present in serum. Furthermore, the kinetics of these reactions in serum, which 
will be enlarged upon in subsequent communications, are considerably different 
from those in isolated systems. If the role of the complement system in path- 
ologic studies is to be characterized, it would seem appropriate to explore the 
reaction  in  a  milieu more closely approximating in vivo conditions.  Further 
studies on these molecular and antigenic alterations of C3 in serum, as well as 
the  functional  capabilities  of  its  conversion  products,  are  now  in  progress. 
SUMMARY 
During the reaction of an immune precipitate with fresh human serum, C3 
undergoes a number of molecular alterations with the formation of conversion 
products  differing  from  those  obtained  when  purified  components  react. 
Those products  which  remain in  the fluid  phase,  the  subject  of the  present 
paper, have been identified by their reaction with monospecific antisera to the 
three antigenic determinants of C3, A, B, and D, after electrophoresis in agar 
or polyacrylamide gel. 
When purified C3 reacts with EAC1, 4, 2, C3i is found in the fluid phase. C3i, a 
loose complex of C3a and C3b, is in a  conformational state whereby only the 
A  and D  antigens, present on its C3b portion, will consume antibody. The B 678  ALTERATIONS  OF  SERUM  C3  IN  IMMUNE  REACTIONS 
antigen, present on the C3a portion of C3i, is unavailable for combination with 
antibody  until  C3i  dissociates. 
In the fluid phase of the reaction of an immune precipitate with whole serum, 
C3i, C3a, and C3b, formed when purified components react, cannot be found. 
Instead the end products of the reaction appear to be C3c, which contains the 
A antigen, and C3d, which contains the D  antigen. C3c and C3d are similar to 
the 151A and a2D produced by the aging of serum but differ in their mobilities 
in  acrylamide gel  and  in  agar.  The  C3c  and  C3d  generated  by an  immune 
precipitate also differ slightly from the C3c and C3d produced by the reaction 
of trypsin with C3 in whole human serum. 
As  human  serum  reacts  with  an  immune  complex,  native  C3  appears  to 
undergo  a  primary alteration  before conversion. This alteration  results  in  a 
molecular  species  of  C3  which  is  labile  at  56°C  for  30  min,  fails  to  expose 
additional A  and D  antigenic sites upon aging, and which forms/31A and C3d 
rather than ~IA and a2D during aging. 
In  addition  to  this  altered  form of native  C3,  a  new  conversion product, 
C3x,  is  formed as  whole serum reacts  with  an  immune complex.  C3x  is  not 
found in systems utilizing pure complement components. C3x is like C3 in that 
it  bears  all  three  antigenic  determinants  but  differs in  that  it  has  a  slightly 
faster  mobility in  polyacrylamide gel  than  does  native  C3.  C3x  is  not  only 
found in the fluid phase but is also bound to the immune precipitate. 
Finally,  the  fluid-phase kinetics  of  each  of  the  antigens  of  C3  have  been 
determined as normal human serum reacts with an immune precipitate. These 
illustrate that nearly the entire population  of native C3  molecules  undergoes 
conversion rapidly as manifested by the disappearance of the B  antigen  from 
the  fluid phase.  Moreover,  the  kinetics  of the  fluid-phase  A  and  D  antigens 
reflect  that  the  conversion of  C3  in  serum is  quantitatively  not  the  same as 
when purified C3 reacts with C4, 2. 
The authors wish to acknowledge the able technical assistance of Mrs. Mary Wang. 
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